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Abstract
The POpulation HEalth Model (POHEM) is a health microsimulation model that was developed at Statistics Canada
in the early 1990s. POHEM draws together rich multivariate data from a wide range of sources to simulate the
lifecycle of the Canadian population, specifically focusing on aspects of health. The model dynamically simulates
individuals’ disease states, risk factors, and health determinants, in order to describe and project health outcomes,
including disease incidence, prevalence, life expectancy, health-adjusted life expectancy, quality of life, and healthcare
costs. Additionally, POHEM was conceptualized and built with the ability to assess the impact of policy and program
interventions, not limited to those taking place in the healthcare system, on the health status of Canadians. Internationally,
POHEM and other microsimulation models have been used to inform clinical guidelines and health policies in relation to
complex health and health system problems. This paper provides a high-level overview of the rationale, methodology,
and applications of POHEM. Applications of POHEM to cardiovascular disease, physical activity, cancer, osteoarthritis, and
neurological diseases are highlighted.
Introduction
The POpulation HEalth Model (POHEM) was conceived
and developed at Statistics Canada in the early 1990s.
POHEM was built in response to concerns about a lack
of data around population health status and health out-
comes [1]. Additionally, the traditional focus of health
policy on funding an increasingly expensive healthcare
system was coming into question. Policymakers wanted
a solid understanding of population health benefits and
implications for resource allocation when making deci-
sions regarding the comparative merits of a range of
health interventions [1]. At that time, a new concept of
population health was emerging in Canada as a result
of the 1974 Lalonde report that identified determinants
of health outside of the healthcare system [2]. Lalonde,
and later Evans and Stoddart [3, 4] among others,
called for a broader perspective on the determinants of
health, emphasizing the role of the social environment.
Pervasive evidence was then coming to light of the
strong correlation between socioeconomic status and
health, which created a growing appreciation that the
impact of medical interventions and the healthcare
system on health was much less than thought[4]. This
perspective necessitated a corresponding broader set of
health information, including data that captured health
status, health outcomes, and the effect of health inter-
ventions [1].
A comprehensive system of health statistics was
proposed [1, 5]. The system centered around the life-
cycle of the individual, and incorporated the external
environment (physical, social, and economic) as well as a
range of interventions both individual (e.g. cholesterol-
lowering medication) and collective (e.g. smoking bans).
The POHEM mircosimulation model was the central
part of this proposed system. POHEM allowed for the
simulation of the lifecycle dynamics and the health
status and health outcomes of the Canadian population
by integrating multivariable data collected from a range
of sources and by projecting hypothetical alternative
population distributions of health outcomes where one
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or more factors could be changed based on an interven-
tion [1]. POHEM was conceptualized and built with the
ability to assess the impact of a wide range of policy and
program interventions, not limited to those taking place
in the healthcare system, on the health status of the
Canadian population.
In population health, policy and program evaluation has
traditionally been undertaken after implementation. This
approach has a number of drawbacks. First, knowing that
large-scale expensive programs can sometimes fail, policy-
makers may be reluctant to implement them despite their
potential benefits. Second, failure or unforeseen conse-
quences of the policy or program may only be revealed
after pilot studies or full implementation. Along with
other modeling methodologies, microsimulation modeling
offers a method of evaluation that allows policymakers to
examine the results, consequences, and benefits of a pro-
gram in advance of implementation [6]. These methods,
while typically used to evaluate programs outside health-
care (e.g., taxation and pension policy)[7], are becoming
increasingly used in the health arena [6, 8–10]. Inter-
nationally, substantial progress has been made using
microsimulation modeling to inform health policy, es-
pecially in the areas of cancer treatment, obesity, and
chronic disease [11–14]. Beyond policy and program
evaluation, microsimulation methods can also play an
important role in population or public health planning.
In Canada, agencies such as Statistics Canada, Health
Canada, the Public Health Agency of Canada (PHAC),
and the Canadian Partnership Against Cancer (CPAC)
have all employed microsimulation models to project
future incidence and prevalence of risk factors and dis-
eases, and future demands for healthcare resources
[15–24]. These projections are useful for planning and
implementation of large scale public health programs,
and can also constitute a “business case” for policy-
makers. POHEM is one such model.
The purpose of this paper is to provide a high-level
overview of the rationale, methods and applications of
POHEM. The following discussion of microsimulation
and POHEM is largely non-technical. Interested readers
are referred to the following citations for additional
details [1, 7, 16, 18–28].
Overview of methods
What is POHEM?
To describe POHEM, it is first necessary to define
dynamic microsimulation. Dynamic microsimulation, in
the context of social science and population health, is
the simulation of large samples of individuals (micro)
and their behaviours, states and actions, over time (dy-
namic), in order to project the socioeconomic and
demographic developments of society [7]. By necessity,
individuals’ behaviours, states and actions are modeled
using multiple sources of empirical data, including cross-
sectional surveys, longitudinal surveys, administrative da-
tabases, vital statistics, and Census data. See Fig. 1 for an
illustration of the data sources used in the POHEM car-
diovascular disease model and the Appendix for a more
comprehensive description of each data source. The expli-
cit microanalytic foundation of these models is important
in representing realistic population heterogeneities and is
conducive to simulating the effects of policy interventions.
POHEM is one of a few population-based health
dynamic microsimulation models worldwide; Zucchelli
et al. and others have reviewed the field [6, 8–10]. The
model dynamically simulates individuals’ disease states,
risk factors, and health determinants, in order to
describe and project health outcomes, including disease
incidence, prevalence, life expectancy, health-adjusted
life expectancy, health-related quality of life, and health-
care costs. POHEM simulates discrete events, such as
changes in disease states, on a case-by-case basis in con-
tinuous time. Events occur in chronological sequence at
specific moments in time and the probability of an event
occurring, or more precisely, the time to an event, is
determined by a random process that draws from empir-
ically observed and estimated waiting time distributions
for each event. The occurrence of diverse events is
embedded in a competing risk framework, that is, events
compete with each other to be the next to occur. As
events occur they influence subsequent draws from the
relevant waiting time distributions, and hence the life
trajectory of the individual. These many random compo-
nents allow individuals’ life course trajectories to vary in
ways that realistically reproduce observed patterns of be-
havior, including variation that is not “explained” by
conventional epidemiological risk functions. The result-
ing variability in simulated individuals’ life course tra-
jectories builds on the variations in the initial values
assigned to the simulated individual. The resulting life
trajectory of each simulated individual is influenced by
exposure to simulated real world events, such as smok-
ing initiation, changes in body mass index (BMI), and
incidence of disease.
How does POHEM work?
Producing estimates from POHEM involves six steps,
described below and in Fig. 2.
Step 1- Model specification Model specification or
conceptualization is a critical step, involving in-depth
consultation among microsimulation experts, clinical
and population health experts, and policymakers [29]. In
this process, priority policy questions to be addressed,
model functionalities (e.g. potential interventions and
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key outcome variables), and the policy-relevant and
feasible counterfactual scenarios are decided.
Step 2- Initialization POHEM can be initialized in two
different ways. The first approach creates a synthetic
population of Canadians. Synthetic populations are ones
where the individual simulated lives are completely
hypothetical. They are generated based on individual-
level data, but the information extracted from these data
mainly take the form of transition patterns among health
and socioeconomic states – for example, fertility rates,
patterns of smoking initiation, and risks of developing
cancer or a heart attack. These simulations generate
“cases”, i.e. individual synthetic biographies, starting at
birth and moving through life event by event until death.
These simulations calibrate historical births so that,
when combined with mortality hazards, the age-sex
structure of the population is complete and representa-
tive from 1971 to 2005, and a full population is pro-
jected until 2050 based on Statistics Canada’s official
population projections [30]. An important advantage of
simulating with a synthetic cohort is the coverage of
individuals’ full life course, including risk exposures,
from birth to death. The challenge is a lack of historical
information about risk exposures, for example smoking.
The second approach creates a starting population
from a cross-sectional survey of Canadians, weighted to
reflect the whole population over the age of 20 years
(approximately 22.5 million people). Most current
POHEM models are initialized in 2001, and reflect the
population base of the 2001 Canadian Community
Health Survey 1.1 (CCHS). A key advantage of using the
initial or start-up population directly from a survey is
that it provides a wide set of individual characteristics
where the multivariate joint distribution of these vari-
ables is empirically based, and draws on a large number
of respondents (CCHS 1.1 n = 105,908) [31]. These vari-
ables include important socio-demographic variables
(sex, age group, province of residence, ethnicity, immi-
grant status, education level, income quartile), health
risk variables (BMI, diabetic status, smoking status,
hypertension status), and health status variables (history
of selected diseases and the Health Utility Index 3). See
Table 1 for an illustration of covariates in the POHEM
cardiovascular disease model. These variables provide
starting values for model actors’ attributes which are
updated and transitioned in Step 3 (described below).
Fig. 1 Schematic diagram of POHEM-cardiovascular disease (CVD) model. The schematic diagram of the POHEM-CVD model shows the variables,
data sources (green boxes), risk factors (yellow circles) and risk algorithms (blue boxes) modelled to project cardiovascular outcomes (pink oval).
Notes: * A detailed description of the data sources is available in Appendix. CHHS = Canadian Heart Health Study, NPHS = National Population
Health Survey, CHHS = Canadian Community Health Survey, DAD = Discharge abstract database, BMI = body mass index, Chole = Cholesterol, HDL
= high density lipoprotein, DPoRT = diabetes population risk tool, AMI = acute myocardial infarction
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The initial values of the variables are used as-is (after
imputation and clean-up of the CCHS data file) or
sometimes modified using an external data source. For
instance, the initial estimate of diabetes prevalence based
on self-reported data was modified to reflect the rate of
diabetes prevalence in a disease-specific registry.
The initialization database could be replaced or sup-
plemented with other cycles of the CCHS (or another
similar survey) that contain more information about
specific risk factors. For example, the CCHS does not
include physical measures such as blood pressure and
lipid levels. Instead, these values are imputed from the
Canadian Heart Health Survey (CHHS). Together the
CCHS, the CHHS, and other population-based surveys
provide a suite of general and detailed health informa-
tion and share more than 20 basic sociodemographic
and behaviorial risk variables, which allows for imput-
ation [32]. A disadvantage of this approach is that the
extent of heterogeneity in the starting population is
limited by the initial sample size and by any imputation
done to prepare the file for simulation. Another disad-
vantage is that historical information on the duration of
time with a condition or exposure is unknown (e.g., cu-
mulative pack years smoked) and needs to be imputed.
Step 3- Dynamic updates and risk transitions Once the
start-up population is established, individuals’ disease
states, risk factors, and health determinants are updated
and dynamically modeled. Transitions of basic socio-
demographic characteristics (age, births and deaths, im-
migration, and emigration and socioeconomic status) of
individuals are simulated. In addition, individuals’
Fig. 2 Process of producing estimates from a POHEM model. The figure presents a flow diagram to summarize the 6 step process of producing
estimates from a POHEM model. Additional detail about each step of the process is provided in the body of the manuscript
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Table 1 Covariates and risk factors in POHEM heart disease model
CVD risk factors
(# categories)
Data sources POHEM Covariates (# categories)- Notes: SES = socioeconomic status, HS = health status, HUI = health utilities index, BMI = body mass index,
CHHS = Canadian Heart Health Study, NPHS = National Population Health Survey, CHS = Canadian Health Study, CHHS = Canadian Community
Health Survey, HDL = high density lipoprotein
Demographics SES Chronic disease profile
































Obesity (4) NPHS (1996/97- 2004/05) √ √ √ √ √
Diabetes (2) NPHS (1996–97) √ √ √ √ √ √


















Data sources POHEM Covariates (# categories)- Notes: SES = socioeconomic status, HS = health status, HUI = health utilities index, BMI = body mass index,
CHHS = Canadian Heart Health Study, NPHS = National Population Health Survey, CHS = Canadian Health Study, CHHS = Canadian Community
Health Survey, HDL = high density lipoprotein
Biophysical measures HS Health behaviours
Initial data source Blood pressure (5) Total cholesterol and HDL (5) HUI (continuous) BMI/previous BMI (4) Smoking (3) Alcohol consumption (4) Nutrition (2)
Blood pressure(5) Imputed using CHHS (1990) √ √
Total cholesterol
and HDL (5)
Imputed using CHHS (1990) √ √
Obesity (4) NPHS (1996/97- 2004/05) √
Diabetes (2) NPHS (1996–97) √ √ √
Smoking (3) CHS (1979), NPHS (1994)
and CCHS (2008)














disease states, risk factors, and health determinants are
changed dynamically by applying predictive algorithms
and risk transition models. For example, in the POHEM
cardiovascular disease model, the established risk factors
for heart disease are updated each year for each actor
from 2001 onwards. Each risk factor (including blood
pressure levels, cholesterol levels, obesity, diabetes, and
smoking) has an empirically-derived equation that pre-
dicts the transition of an individual from one risk factor
category to another (or from one value to another, for
those risk factors described continuously – e.g. BMI).
See Table 1 for data sources used to derive the equations.
Step 4- Validation and calibration Once the dynamic
updates and risk transitions are applied, the estimates of
the health outcomes of interest are validated. The
POHEM model is validated internally (the computer
code and parameter values are checked against the out-
puts) and where possible externally (the estimates are
compared against other sources of data not used to build
the model). In addition estimates are validated by spe-
cific subgroups of the population, for instance by prov-
ince, age, and sex. In the case of disease incidence, such
as acute myocardial infarction (AMI), POHEM projec-
tions are checked against estimates from hospital data
(Canadian Institute for Health Information Discharge
Abstract Database). Model output will not always agree
with external benchmarks, such as cancer incidence
rates from the Canadian Cancer Registry. As a result, an
important step is model calibration. Calibration adjusts
selected parameters in the model so that simulated esti-
mates match observed estimates more closely.
Step 5- Projection Once validated estimates are pro-
duced from POHEM, projected estimates of health
outcomes can be examined. For example, the POHEM
cardiovascular disease model currently projects esti-
mates of heart disease risk factor prevalence and AMI
hospitalizations until 2021 (the end-date is modifiable).
It is important to remember that projections of cardio-
vascular disease risk factor prevalence and AMI hospi-
talizations reflect extrapolated “baseline” data, using
current observed trends in risk factor prevalence and
AMI hospitalizations, baseline preventive healthcare
practice, and other baseline societal factors that affect
cardiovascular disease risk. Baseline projections are in-
formed by the baseline risk and health exposures of the
start-up population data and the programmed risk tran-
sitions over time.
Step 6- Counterfactual analysis Once the “baseline” or
“base-case” projection has been established, counterfactual
analysis can begin. Depending on the outcome of interest
Fig. 3 Projected osteoarthritis (OA) prevalence for overweight and obese Canadian men and women to 2031. This figure shows the prevalence
of OA among overweight and obese adult Canadian men and women projected to 2031. The base-case scenario (solid black line) is contrasted
with 2 other scenarios showing the projected prevalence of OA if body mass index (BMI) in 2001 was reduced by 5 points (gray dotted line) or
10 points (gray dashed line)
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the counterfactual scenario can result from applying a
number of different interventions, from increasing the
coverage of cholesterol medications in the population to re-
ducing BMI. Figure 3 presents an illustrative counterfactual
analysis of osteoarthritis (OA) prevalence for overweight
and obese men and women (age 20 years and older) pro-
jected to 2031. The base-case scenario is contrasted with
two other scenarios showing the projected prevalence of
OA if BMI was reduced by 5 points or 10 points.
Overview of applications
POHEM cardiovascular disease model
Many of the examples discussed in this paper come from
the POHEM model of cardiovascular disease (see Fig. 1
and Table 1 for covariates and risk factors modeled).
This model was developed in collaboration with aca-
demic research teams and has been used to investigate
the projected prevalence of risk factors for heart disease
in Canada [33]. POHEM was well-suited for this study
because cardiovascular disease is a complex disease
process, with many contributing risk factors leading to
multiple outcomes. Further, the incidence of cardiovas-
cular disease has declined in the past 50 years, with the
prevalence of risk factors changing significantly. For in-
stance, smoking is in decline while obesity is on the rise,
and the population is aging. The POHEM cardiovascular
disease model has projected decreased smoking rates
but increased obesity prevalence, with obesity projected
to overtake smoking as the most prevalent risk factor by
2017. These projections can inform policymakers inter-
ested in decreasing cardiovascular disease risk and AMI
hospitalizations in the population [33].
POHEM cancer models
POHEM has been used extensively to study major can-
cer sites. Models have been developed to investigate
cancer screening (colorectal and lung) [19, 23] cancer
treatment (lung and breast) [15, 23] and costs of cancer
(breast, colorectal, and lung) [18, 23, 34]. Flanagan et al.
demonstrated that screening for colorectal cancer with
fecal occult blood test and follow-up by colonoscopy
could be cost-effective for the Canadian population but
highlighted that the effectiveness of screening would
greatly depend on reaching high screening participation
rates [19]. These results informed the National Committee
on Colorectal Cancer Screening which made updated
colorectal cancer screening guidelines in Canada. Will et
al. used the POHEM breast cancer model to demonstrate
that while preventive tamoxifen treatment had a substan-
tial benefit in reducing breast cancer incidence and mor-
tality, the detrimental effects of tamoxifen on endometrial
cancer, coronary heart disease, stroke, and deep vein
thrombosis could actually outweigh its protective effects
and even shorten women’s life expectancies overall [15].
The Cancer Risk Management Model (CRMM) is a
spin-off model from POHEM developed by Statistics
Canada in collaboration with CPAC to assess cancer
control strategies in the areas of prevention, screening,
and treatment for four major cancer sites: lung, colorectal,
cervical and breast [23, 24]. They feature sophisticated
natural history models of tumor onset and progression.
Evans et al. projected estimates of future lung cancer inci-
dence with current smoking rates holding steady (approxi-
mately 22 %) and counterfactually with smoking rates
decreasing by 50 % over 3 years [23]. The CRMM lung
module can also be used to compare the cost-effectiveness
of similar smoking cessation initiatives to alternative inter-
ventions, including introduction of new screening pro-
grams, for instance, low dose CT scanning to detect early
lung cancer [23, 24, 35]. The CRMM colorectal model has
been used to evaluate different screening modalities (fecal
occult blood, fecal immunological test, sigmoidoscopy and
colonoscopy) under a range of program characteristics
(age range, frequency, participation rates, costs) at a
provincial level, as well as to assess the potential cost-
effectiveness and budgetary impacts of implementation
[36]. The CRMM cervical model can be used to evaluate
the potential reorganization of cervical cancer screening
in the context of vaccination for human papillomavirus
(HPV) and HPV DNA testing. A wide range of scenarios
have been evaluated to inform the Canadian Cervical
Cancer Screening Network. This example illustrates the
power of microsimulation to evaluate multiple interven-
tion strategies including prevention, screening, and treat-
ment, and provides common metrics with which to
compare them. CRMM has also been made available on
the web for easy use by cancer control and health policy
analysts, who can use it to evaluate different cancer
control strategies [23, 24].
POHEM osteoarthritis model
Osteoarthritis (OA) is the most common form of arth-
ritis and a leading cause of disability in Canada. OA is a
chronic condition of aging and as our population ages,
increasing numbers of people are living with this condi-
tion and suffering reductions in their health-related
quality of life. In addition, OA is costly to the health-
care system, entailing drug and surgical treatment. The
POHEM model provides a tool for researchers and
policymakers to examine important outcomes of OA
simultaneously. Kopec et al. developed POHEM–OA to
quantify the future health and economic burden of OA
under a range of scenarios incorporating changes in a
key OA risk factor (BMI) and treatment levels (medica-
tions and surgery). Simulation modeling allowed these re-
searchers to assess the future impact of potential changes
in BMI on the prevalence of OA across population groups
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(see Fig. 3) [20]. In addition, this model also allowed
researchers to examine the effects of BMI reduction on
OA incidence and health-related quality of life [37], as well
as projecting the direct [38] and indirect costs of OA in
the next 20 years.
POHEM physical activity model
POHEM-Physical Activity (PA) was developed in collab-
oration with PHAC to project different types of physical
activity and assess the potential impact of physical activ-
ity on health outcomes, such as number of cases of dis-
ease (diabetes, hypertension, heart disease, and cancer)
and health-adjusted life expectancy. The Conference
Board of Canada used POHEM-PA to do counterfactual
analysis of increasing physical activity among 10 % of
Canadians and examined the impacts on chronic disease
incidence and ultimately the Canadian economy [39].
The POHEM-PA model methodology has been formally
published [22].
POHEM neurological model
POHEM-Neurological was developed in collaboration with
PHAC to project the incidence and prevalence of neuro-
logical conditions as well as their impact on health-related
quality of life, healthcare costs and caregivers [25]. The
most prevalent neurological conditions were modeled:
Alzheimer’s disease and other dementias, cerebral palsy,
epilepsy, multiple sclerosis, Parkinson’s disease/parkinson-
ism, hospitalized traumatic brain injury, and hospitalized
traumatic spinal cord injury. Each model accounted for
changes in the Canadian population from births, immigra-
tion, emigration, and aging; however, risk factors were not
included in this version of the model [25].
Discussion
POHEM was conceived as a policy analysis tool in the
early 1990s. Now, more than ever, policymakers want to
use evidence-based comparative evaluations of cost and
benefit when deciding to implement new medical and
non-medical interventions [40]. Many of the most im-
portant health policy questions—for instance, trends in
cardiovascular disease, cancer, OA, obesity, and demen-
tia—are challenging to examine and therefore require
robust and comprehensive planning models. Further-
more, Canada and other developed countries are faced
with aging populations that will require more healthcare
resources. Population aging and worsening health attri-
butes, like obesity, may be contributing to a rise in
chronic disease prevalence and health system costs.
POHEM’s dynamic microsimulation structure is an at-
tractive methodology to investigate complex health and
health system problems.
Internationally, microsimulation and other modeling
strategies have been gaining traction and have been used
to inform policy in relation to complex health and health
system problems. For example, in the United States a
modeling collaborative funded by the National Cancer
Institute, the Cancer Intervention and Surveillance
Modelling Network (CISNET), has been used to in-
form decisions about cancer treatment and screening
as well as coverage of these services by Medicaid and
Medicare [11, 40]. CISNET has also contributed sub-
stantially to the development of the microsimulation
modeling field by using best practices for modeling,
validation, and model documentation [11, 40]. In the
United Kingdom, the Foresight model has been used
to investigate the future burden and costs of over-
weight and obesity [12]. More recent work has focused
on the impact of prevention strategies on obesity re-
lated disease [13]. In Australia, Health&Wealth-
MOD2030 has been used to project the economic
impacts of early retirement from ill-health [14]. Col-
lectively these and other simulation models have made
inroads into our understanding of the health and eco-
nomic impacts of cancer and chronic diseases as well
as highlighting population-based prevention, treat-
ment, and screening strategies. These models share
many common attributes with POHEM. Specifically,
they can be used to compare and evaluate a wide
range of intervention strategies, including prevention,
early detection, and therapeutic options, to assess
strategies to reduce healthcare costs and improve
health outcomes.
By projecting policy-relevant health outcomes, micro-
simulation models have the potential to allow policy-
makers to foresee the effects of policy. POHEM has the
ability to assess multiple important health outcomes at
the population level. While incidence and prevalence of
disease are important health outcomes, these metrics
only provide a piece of the story. Outcomes such as
health-adjusted life expectancy provide a more salient
picture of the full impact of disease. Projected costs of
disease and treatment are another very important re-
sult, especially from a policy perspective [40]. For
example, the CISNET and CRMM models can project
the effect of smoking reduction on disease incidence,
health resource use, and government revenues [24, 40].
In addition, microsimulation models can be useful for
planning large-scale public or population health pro-
grams, such as decreasing the population’s BMI or in-
creasing physical activity [20, 22, 39].
Implementing interventions on a large scale can be
expensive and the results can be unpredictable. This
methodology allows policymakers to simulate the effect
of proposed interventions, and compare different inter-
ventions targeting different segments of the population
[6]. The types of intervention modeled can grow beyond
the health system to incorporate empirical data from
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any policy sphere of interest, including economic, educa-
tion, and environmental policy [1]. This is an important
feature if policymakers are concerned with tackling
the social determinants of health and examining the
distributional effects of health policies and interven-
tions, the only caveat being that plausible scenarios
can be constructed to model behaviour change as a re-
sult of interventions.
The breadth of information within population-
microsimulation models like POHEM has begun to
achieve the original vision of creating a comprehensive
system of health statistics [1, 5]. In the United States,
the Alzheimer’s Association releases an annual report
with a wide range of statistics including disease pro-
jections, caregiving burden, and health care costs.
POHEM-Neurological could be used to estimate al-
most all these measures from a single software plat-
form, with the additional benefit of allowing
counterfactual examination and sensitivity testing that
will simultaneously project forward over a dozen health
measures, including disease prevalence, years of life lost,
healthy years of life lost, health care costs, and hours of
caregiving [25].
Like all approaches, micrsosimulation has limitations.
Three important limitations include intensive data re-
quirements, difficulty quantifying and showing uncer-
tainty estimates around model projections, and difficulty
summarizing and describing the models. First, the esti-
mates and projections produced by POHEM are only as
good as the data input. Gathering, incorporating, and
ensuring the quality of data is an intensive process.
Ideally, data inputs reflect the Canadian population
which, in practice, places a high level of reliance on
population-based surveys and administrative data. Con-
cerns with these data include sampling error, incomplete
coverage, non-response, and measurement error—all of
which can lead to biased results. Dynamic transitions are
preferably estimated using longitudinal studies with re-
peated exposure and outcome measures; however, these
data are uncommon. An important Canadian source of
this data was Statistics Canada’s the National Population
Health Survey (NPHS).
Second, it is technically challenging to quantify
uncertainty estimates around model projections, yet
producing such estimates is essential to establish model
validity and credibility. These methods have been devel-
oped for some CISNET models and are currently under
development for POHEM [41, 42]. Finally, microsimu-
lation models can be extremely complex and have been
criticised as being “black boxes.” Uptake and use of
these models for population health planning and health
policy evaluation requires clear communication of the
methodology and assumptions used. Comprehensive
model assessment, including documentation of the data
sources used, quantification of the uncertainty around
model projections, and clear communication of the
methodology can establish model credibility and facili-
tate uptake by policymakers [9, 40]. Concerted efforts
are being made to develop, assess, document, and use
these models to answer policy-relevant questions. Spe-
cifically, the International Journal of Microsimulation,
launched in 2009, has provided an avenue for re-
searchers to publish the technical details of model de-
velopment, which are of limited interest to those
outside the field [43]. Further, reviews and guidelines
now exist to guide researchers when constructing,
validating, and reporting on microsimulation models
[21, 29, 41, 44, 45].
Conclusion
This paper has traced the origins of the POpulation
HEalth Microsimulation model, sketched how it works,
and provided examples of its application. Microsimula-
tion modeling has been well established in socioeco-
nomic policy (e.g. taxation) as well as other fields of
science (e.g. environmental studies and cosmology) for
many decades. Its uptake in the health field has been
slow but increasing. Using POHEM as an example, this




Canadian Census of Population and Statistics
Canada official population projections — The census
is Canada’s largest and most comprehensive data source.
Every 5 years the Census of Population collects demo-
graphic and linguistic information on every man, woman
and child living in Canada and is the main source of data
available in a standardized format for small areas. It pro-
vides nationally comparable data that can be cross-
classified to show details. It is also the main body of
comprehensive statistical data at the sub-provincial level
on Canada’s population. The data are needed by both
the public and private sectors to support decision-
making in many areas, for example, to plan community
services such as health care, schools, day care, police
services and fire protection. Census information is used
by the Demography Division at Statistics Canada to pro-
duce future projections of the numbers od new births
and immigrants by age, sex and year of birth. In
POHEM these data are used to initialize and update the
population structure over time.
Vital Statistics—Provincial and territorial Vital Statis-
tics Acts (or equivalent legislation) render compulsory
the registration of all live births, stillbirths, deaths and
marriages within their jurisdictions. Under the
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agreement, all registrars collect a specified set of data
elements, although any of them may decide to collect
additional information. The central Vital Statistics Registry
in each province and territory provides data from death
registrations to Statistics Canada. This information is col-
lated into statistical reports of mortality rates and causes of
death. This information is used by the Demography Div-
ision, who generate the official population projections (see
above), which in turn are used in POHEM.
Canadian Community Health Survey (CCHS)—The
CCHS is a cross-sectional survey started in 2000/01 with
a sample size of 131,535. It was initially repeated every two
years but as of 2009, data is collected on an ongoing basis
to provide annual estimates. The CCHS was designed to
be representative of the Canadian household population
aged 12 years and older and elicited a wide range of self-
reported information related to health status, health care
utilization and health determinants. The CCHS survey and
sampling strategies have been described in detail elsewhere
[31]. The CCHS 2000/01 survey was used to define the ini-
tial population of the POHEM: CVD model that was pro-
jected forward in time by the simulation.
Canadian Heart Health Survey (CHHS)—The CHHS
are cross-sectional surveys conducted separately in each
of the ten provinces between 1986 and 1992. These sur-
veys were designed to gather information on risk factors
associated with cardiovascular disease for individuals
aged 18–74 years and had a combined sample size of
23,129. Unlike the CCHS, the CHHS also collected phys-
ical measures such as blood pressure and cholesterol.
The CHHS survey and sampling strategies have been
described in detail elsewhere [46]. In POHEM: CVD the
CHHS dataset was used to initialize blood pressure and
cholesterol variables and to impute values of blood pres-
sure and cholesterol into the CCHS to allow the risk
transitions for these risk factors to be updated yearly.
National Population Health Survey (NPHS)—The
NPHS is a longitudinal survey started in 1994/95 with a
sample of 17,276 individuals aged 12 years and older.
The survey is conducted every two years and currently
has 18 years of follow-up. Like the CCHS, the NPHS
elicited a wide range of self-reported information related
to health status, health care utilization and health deter-
minants. The NPHS survey and sampling strategies have
been described in detail elsewhere [47]. In POHEM:
CVD, the NPHS data set was used to model risk factors
related to health behaviour and diabetes prevalence.
Discharge Abstract Database (DAD) — Data on hos-
pitalizations for AMI were obtained from the Canadian
Institute of Health Information (CIHI) Discharge Abstract
Database (DAD), which is a national database containing
basic demographic, administrative and clinical data on hos-
pital discharges across Canada, excluding the province of
Quebec. CIHI receives data directly from participating
hospitals. These include all public hospitals in every prov-
ince and territory, except Quebec.
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